C12N 2502/088
Neural stem cells
Official title: neural stem cells
C12N2502/088 (Neural stem cells) appears on 34 US grants and 50 published applications in this corpus.
Search patents in C12N- Granted patents
- 34
- Published applications
- 50
- Assignees
- 25
- Inventors
- 82
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 2 | 0 |
| 2014 | 1 | 3 |
| 2015 | 1 | 1 |
| 2016 | 0 | 5 |
| 2017 | 2 | 1 |
| 2018 | 1 | 7 |
| 2019 | 2 | 4 |
| 2020 | 5 | 9 |
| 2021 | 2 | 2 |
| 2022 | 3 | 4 |
| 2023 | 4 | 4 |
| 2024 | 4 | 2 |
| 2025 | 2 | 0 |
| 2026 | 4 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods of bioengineering internal anal sphincter constructs22 Sep 2026US 12,741,058 B2Wake Forest University Health Sciences
- High-expression type mesenchymal stem cells, culture method and use thereof9 Jun 2026US 12,649,902 B2Gwo Xi Stem Cell Applied Technology Co., Ltd.
- Xeno-free and transgene-free reprograming of mesenchymal stem cells toward neural progenitor cells17 Mar 2026US 12,577,532 B2Institute for Scientific Research and Technology Services (Indicasat)
- Microfluidic device for cerebrovascular simulation and high-efficiency blood-brain barrier simulation system comprising same3 Feb 2026US 12,540,297 B2Cellartgen Inc.
- Microfluidic model of the blood brain barrier5 Aug 2025US 12,378,519 B2Cedars-Sinai Medical Center
- Xeno-free and transgene-free reprograming of mesenchymal stem cells toward neural progenitor cells1 Oct 2026US 2026/0297516 A1
- Generation of induced pluripotent stem cells with polycistronic sox2, klf4, and optionally c-myc6 Aug 2026US 2026/0226422 A1Beixcell (Beijing) Biotechnology Ltd.
- Methods of treating eye diseases using optic nerve lamina region neural progenitor cell-derived secreted extracellular vesicles and free proteins28 May 2026US 2026/0144825 A1University of Maryland, Baltimore
- Methods and compositions for spinal cord cells1 Jan 2026US 2026/0002120 A1Cedars-Sinai Medical Center
- Structurally complete organoids26 Sep 2024US 2024/0318145 A1Children's Hospital Medical Center
Most cited
By later US patents
- Methods of culturing embryonic stem cells and controlled differentiation21US 7,112,437 B2ES Cell International PTE Ltd. · 2006
- Method of co-culturing mammalian muscle cells and motoneurons6US 8,815,584 B1University of Central Florida Research Foundation, Inc. · 2014
- Culturing human embryonic stem cells with a noggin to generate cells lacking Pax-6 expression3US 9,080,147 B2ES Cell International PTE Ltd. · 2015
- Method of co-culturing mammalian muscle cells and motoneurons3US 9,650,606 B2University of Central Florida Research Foundation, Inc. · 2017
- Methods for treating a brain tissue damage by cultured adult pluripotent olfactory stem cells1US 10,696,945 B2China Medical University · 2020